chr7-45657899-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PM2BP4_StrongBP6_Very_Strong
The NM_021116.4(ADCY1):c.1307+14G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000139 in 1,579,072 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000059 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000091 ( 0 hom. )
Consequence
ADCY1
NM_021116.4 intron
NM_021116.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.884
Genes affected
ADCY1 (HGNC:232): (adenylate cyclase 1) This gene encodes a member of the of adenylate cyclase gene family that is primarily expressed in the brain. This protein is regulated by calcium/calmodulin concentration and may be involved in brain development. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 7-45657899-G-A is Benign according to our data. Variant chr7-45657899-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 506197.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADCY1 | NM_021116.4 | c.1307+14G>A | intron_variant | ENST00000297323.12 | |||
ADCY1 | NM_001281768.2 | c.632+14G>A | intron_variant | ||||
ADCY1 | XM_005249584.4 | c.1307+14G>A | intron_variant | ||||
ADCY1 | XM_005249585.3 | c.1307+14G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADCY1 | ENST00000297323.12 | c.1307+14G>A | intron_variant | 1 | NM_021116.4 | P1 | |||
ADCY1 | ENST00000432715.5 | c.632+14G>A | intron_variant | 2 | |||||
ADCY1 | ENST00000621543.1 | c.632+14G>A | intron_variant | 5 | |||||
ADCY1 | ENST00000646653.1 | n.248+14G>A | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152110Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
8
AN:
152110
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000922 AC: 2AN: 217002Hom.: 0 AF XY: 0.00000857 AC XY: 1AN XY: 116702
GnomAD3 exomes
AF:
AC:
2
AN:
217002
Hom.:
AF XY:
AC XY:
1
AN XY:
116702
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000911 AC: 13AN: 1426846Hom.: 0 Cov.: 34 AF XY: 0.00000707 AC XY: 5AN XY: 707288
GnomAD4 exome
AF:
AC:
13
AN:
1426846
Hom.:
Cov.:
34
AF XY:
AC XY:
5
AN XY:
707288
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152226Hom.: 0 Cov.: 33 AF XY: 0.0000672 AC XY: 5AN XY: 74432
GnomAD4 genome
AF:
AC:
9
AN:
152226
Hom.:
Cov.:
33
AF XY:
AC XY:
5
AN XY:
74432
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 27, 2017 | c.1307+14G>A in intron 6 of ADCY1: This variant is not expected to have clinical significance because it is not located within the splice consensus sequence and it is not predicted to impact splicing. It has been identified in 3/21172 Afric an chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadin stitute.org). ACMG/AMP Criteria applied: BP4, BP7. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at